CARLSBAD, Calif.--(BUSINESS WIRE)--Feb. 7, 2005--Orange 21 Inc.
(Nasdaq: ORNG) today announced that Tracy Meier has joined the company
as Vice President and General Counsel. Ms. Meier most recently served
as the chief legal counsel at Biolase Technology, Inc.
"Tracy joins Orange 21 with nearly 20 years of legal experience at
a number of high growth public companies," said Barry Buchholtz, Chief
Executive Officer. "As a newly public company, we will benefit from
her expertise in corporate governance, SEC compliance and operations.
Furthermore, as we look to grow the company by expanding our marketing
and distribution efforts throughout the United States and
internationally and developing and acquiring new products and brands,
Tracy's background in corporate law, including product distribution
and manufacturing collaborations, will help us to achieve our goals."
"I am delighted to join Orange 21 at this exciting time and look
forward to contributing to the company's continued success," said Ms.
Meier.
At Biolase Technology, Inc., Ms. Meier concentrated on compliance
and reporting, as well as drafting and reviewing corporate agreements
for manufacturing and research and development collaborations,
intellectual property licenses, real estate leases, product
distribution and employment contracts. Previously, Ms. Meier served as
Vice President and General Counsel for Senomyx, Inc. and corporate
counsel at IDEC Pharmaceuticals Corporation, now Biogen Idec, Inc.,
and handled litigation for American International Group, Inc., Mentor
Corporation and Holidays Inns, Inc. Ms. Meier holds a B.A. from St.
Leo University and a Law Degree from California Western School of Law.
About Orange 21
Orange 21 designs, develops and markets premium products for the
action sports and youth lifestyle markets. Orange 21's principal
products, sunglasses and goggles, are marketed under its brand, Spy
Optic Inc. ("Spy"), a wholly-owned subsidiary. Spy's innovative
proprietary products utilize high-quality materials, handcrafted
manufacturing processes and engineered optical lens technology to
convey performance, style, quality, and value.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: Certain statements contained in this press release
are not historical facts and may be considered forward-looking
statements, including, without limitation, statements relating to the
company's conversion to a dealer direct business model in France and
Italy, which are based upon a number of assumptions concerning future
conditions that ultimately may prove to be inaccurate. Such
forward-looking statements are subject to risks and uncertainties and
may be affected by various factors that may cause actual results to
differ materially from those in the forward-looking statements.
Further information on potential risk factors that could affect Orange
21's business and its financial results are detailed in its filings
with the Securities and Exchange Commission, including its
Registration Statement on Form S-1 declared effective on December 13,
2004. Undue reliance should not be placed on forward-looking
statements, which speak only as of the date that they are made.
CONTACT: Orange 21 Inc.
Michael Brower, 760-804-8420
mbrower@spyoptic.com
or
Integrated Corporate Relations, Inc.
Andrew Greenebaum, 310-395-2215
agreenebaum@icr-online.com
or
Christine Lumpkins, 310-395-2215
clumpkins@icr-online.com
SOURCE: Orange 21, Inc.